ANTABIO logo — Developing Tomorrow's Antibacterials

ANTABIO

Developing Tomorrow's Antibacterials

Founded 2009 France France 25 employees Series B Total: $52.23M Biotechnology, Life Sciences +1

General Information

Company Name ANTABIO
Founded Year 2009
Location France France
Employees 25
Industries Biotechnology, Life Sciences, Medical Devices
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with ANTABIO. To contact ANTABIO, visit antabio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ANTABIO compare?

A PDF of ANTABIO and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ANTABIO soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ANTABIO

Antabio is a privately-held clinical-stage biopharmaceutical company founded in 2009, with a focus on developing novel and highly differentiated antibacterial treatments for drug-resistant infections. The company operates in the biotechnology, life sciences, and medical devices industries and is based in France. Antabio recently secured a significant €25.00M Series B investment on 12 December 2023. The investment was led by a consortium of prominent investors including BNP Paribas Developpement, European Innovation Council, Turenne Capital, AMR Action Fund, IRDI SORIDEC Gestion, and Christophe Ricard. Antabio's focus on combating infections caused by CDC and WHO critical priority pathogens underscores its commitment to addressing pressing global health challenges. For more information, visit Antabio's website at www.antabio.com and follow them on Twitter at @antabio.

Business keywords: biopharmaceutical, antibacterial treatments, drug-resistant infections, metalloenzymes inhibitors, bacterial Metallo ß-lactamases, carbapenem combination, drug discovery, drug development, antibiotic adjuvant, nosocomial infections, clinical-stage, Wellcome Trust Seeding Drug Discovery Award, Labege, France

Funding Rounds & Investors (16)

View All
Funding Stage Amount Investors Lead Investors Date
Series B €25.00M 6
BNP Paribas Developpement, European Innovation Council +4
12 Dec 2023
Grant €2.50M 1
European Innovation Council
15 Jun 2022
Grant €900.00K -
16 Mar 2021
Grant $4.40M 1
CARB-X
02 Jan 2020
Series A Undisclosed -
12 Jul 2018
Series A Undisclosed -
16 Oct 2017
Grant $8.90M 1
CARB-X
25 Jul 2017
Grant €4.00M 1
Wellcome Trust
12 May 2015
Grant €1.00M 1
Bpifrance
09 Apr 2015
Venture Round €90.00K 1
Nubbo Incubator
02 Dec 2014

View All 16 Funding Rounds

ANTABIO Alternatives & Competitors

ANTABIO vs

Delivering Novel Anti-Infectives

Venture round
6 employees
Biotechnology, Health Care
ANTABIO vs

On a mission to tackle pandemic-sized challenges with innovative, oral antiviral treatments, paving...

Post-IPO Equity
Biotechnology, Life Sciences

FAQ About ANTABIO

Developing Tomorrow's Antibacterials
ANTABIO was founded in 2009.
ANTABIO is headquartered in France.
ANTABIO operates in Biotechnology, Life Sciences and Medical Devices. Its work centres on biopharmaceutical, antibacterial treatments, drug-resistant infections and metalloenzymes inhibitors.
ANTABIO has approximately 25 employees.
ANTABIO has completed 16 funding rounds, raising a total of $52.23M. The latest funding stage is Series B.
Top alternatives and competitors to ANTABIO include MGB Biopharma Limited, Pardes Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ANTABIO and MGB Biopharma Limited are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ANTABIO, https://bouncewatch.com/company/antabio, updated 21 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes